During the past decade, Internal Medicine Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Internal Medicine Associates" are "Arthritis" (1 trials), "Diabetes Mellitus, Type 1" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Osteoarthritis" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Internal Medicine Associates" in a lesser frequency.

Most popular intervention types in "Internal Medicine Associates" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "AC2993" (2 trials), "Placebo" (2 trials), "NSAID" (1 trials), "Pramlintide acetate" (1 trials) and "tanezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Internal Medicine Associates" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Internal Medicine Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Internal Medicine Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Internal Medicine Associates, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".